bw a1433u has been researched along with colforsin in 1 studies
| Studies (bw a1433u) | Trials (bw a1433u) | Recent Studies (post-2010) (bw a1433u) | Studies (colforsin) | Trials (colforsin) | Recent Studies (post-2010) (colforsin) |
|---|---|---|---|---|---|
| 26 | 0 | 0 | 13,460 | 46 | 1,298 |
| Protein | Taxonomy | bw a1433u (IC50) | colforsin (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 1.729 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.041 | |
| Adenylate cyclase type 1 | Homo sapiens (human) | 0.0955 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hill, RJ; Magee, W; Masamune, H; Oleynek, JJ; Tracey, WR | 1 |
1 other study(ies) available for bw a1433u and colforsin
| Article | Year |
|---|---|
Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5'-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation.
Topics: Adenosine; Adenylyl Cyclases; Animals; Anti-Arrhythmia Agents; Binding, Competitive; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Decanoic Acids; Dose-Response Relationship, Drug; Glyburide; Hydroxy Acids; Hypoglycemic Agents; Myocardial Reperfusion Injury; Myocardium; Perfusion; Potassium Channels; Rabbits; Receptor, Adenosine A3; Receptors, Purinergic P1; Xanthines | 1998 |